Katherine L. Gill

Characterization of In Vitro Glucuronidation Clearance of a Range of Drugs in Human Kidney Microsomes: Comparison with Liver and Intestinal Glucuronidation and Impact of Albumin

Katherine L. Gill, J. Brian Houston, Aleksandra Galetin · Drug Metabolism and Disposition · 2012 · 114 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

Katherine L. Gill, Iain Gardner, Linzhong Li et al. · The AAPS Journal · 2015 · 106 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Development and Application of a Physiologically-Based Pharmacokinetic Model to Predict the Pharmacokinetics of Therapeutic Proteins from Full-term Neonates to Adolescents

Xian Pan, Felix Stader, Khaled Abduljalil et al. · The AAPS Journal · 2020 · 45 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data

Katherine L. Gill, Michael Gertz, J. Brian Houston et al. · Drug Metabolism and Disposition · 2013 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Simulating the Impact of Elevated Levels of Interleukin-6 on the Pharmacokinetics of Various CYP450 Substrates in Patients with Neuromyelitis Optica or Neuromyelitis Optica Spectrum Disorders in Different Ethnic Populations

Krishna K. Machavaram, Chihiro Endo-Tsukude, Kimio Terao et al. · The AAPS Journal · 2019 · 25 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +10